mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...
Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Wien 104,70 EUR 107,50 EUR-2,80-2,60% 103,70 - 103,70-17:50:06 04.03.2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback